靶向胶质母细胞瘤干性抗原的疫苗诱导 T 细胞受体 T 细胞治疗
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen.
66.3分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen.
NLGN4X TCR transgenic T cells to treat gliomas.
NLGN4X-TCR-T 在临床前胶质母细胞瘤模型中显示出疗效。
Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors.
这种整合分析方法识别出 pDMG 中可靶向的通路、表面抗原和新抗原,支持 CAR-T 和 TCR-T 疗法的开发。这些发现还提示其可能适用于其他携带相同突变的癌症。
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.
Clinical and Translational Advances in Glioma Immunotherapy.
Cellular therapies in sarcoma and other solid tumors.
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy.
共 7 条
MEMBER ACCOUNT
登录成功会直接打开下一页。